Cargando…

Retargeting of microcell fusion towards recipient cell-oriented transfer of human artificial chromosome

BACKGROUND: Human artificial chromosome (HAC) vectors have some unique characteristics as compared with conventional vectors, carrying large transgenes without size limitation, showing persistent expression of transgenes, and existing independently from host genome in cells. With these features, HAC...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiratsuka, Masaharu, Ueda, Kana, Uno, Narumi, Uno, Katsuhiro, Fukuhara, Sayaka, Kurosaki, Hajime, Takehara, Shoko, Osaki, Mitsuhiko, Kazuki, Yasuhiro, Kurosawa, Yoshikazu, Nakamura, Takafumi, Katoh, Motonobu, Oshimura, Mitsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472177/
https://www.ncbi.nlm.nih.gov/pubmed/26088202
http://dx.doi.org/10.1186/s12896-015-0142-z
_version_ 1782377015509254144
author Hiratsuka, Masaharu
Ueda, Kana
Uno, Narumi
Uno, Katsuhiro
Fukuhara, Sayaka
Kurosaki, Hajime
Takehara, Shoko
Osaki, Mitsuhiko
Kazuki, Yasuhiro
Kurosawa, Yoshikazu
Nakamura, Takafumi
Katoh, Motonobu
Oshimura, Mitsuo
author_facet Hiratsuka, Masaharu
Ueda, Kana
Uno, Narumi
Uno, Katsuhiro
Fukuhara, Sayaka
Kurosaki, Hajime
Takehara, Shoko
Osaki, Mitsuhiko
Kazuki, Yasuhiro
Kurosawa, Yoshikazu
Nakamura, Takafumi
Katoh, Motonobu
Oshimura, Mitsuo
author_sort Hiratsuka, Masaharu
collection PubMed
description BACKGROUND: Human artificial chromosome (HAC) vectors have some unique characteristics as compared with conventional vectors, carrying large transgenes without size limitation, showing persistent expression of transgenes, and existing independently from host genome in cells. With these features, HACs are expected to be promising vectors for modifications of a variety of cell types. However, the method of introduction of HACs into target cells is confined to microcell-mediated chromosome transfer (MMCT), which is less efficient than other methods of vector introduction. Application of Measles Virus (MV) fusogenic proteins to MMCT instead of polyethylene glycol (PEG) has partly solved this drawback, whereas the tropism of MV fusogenic proteins is restricted to human CD46- or SLAM-positive cells. RESULTS: Here, we show that retargeting of microcell fusion by adding anti-Transferrin receptor (TfR) single chain antibodies (scFvs) to the extracellular C-terminus of the MV-H protein improves the efficiency of MV-MMCT to human fibroblasts which originally barely express both native MV receptors, and are therefore resistant to MV-MMCT. Efficacy of chimeric fusogenic proteins was evaluated by the evidence that the HAC, tagged with a drug-resistant gene and an EGFP gene, was transferred from CHO donor cells into human fibroblasts. Furthermore, it was demonstrated that no perturbation of either the HAC status or the functions of transgenes was observed on account of retargeted MV-MMCT when another HAC carrying four reprogramming factors (iHAC) was transferred into human fibroblasts. CONCLUSIONS: Retargeted MV-MMCT using chimeric H protein with scFvs succeeded in extending the cell spectrum for gene transfer via HAC vectors. Therefore, this technology could facilitate the systematic cell engineering by HACs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12896-015-0142-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4472177
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44721772015-06-19 Retargeting of microcell fusion towards recipient cell-oriented transfer of human artificial chromosome Hiratsuka, Masaharu Ueda, Kana Uno, Narumi Uno, Katsuhiro Fukuhara, Sayaka Kurosaki, Hajime Takehara, Shoko Osaki, Mitsuhiko Kazuki, Yasuhiro Kurosawa, Yoshikazu Nakamura, Takafumi Katoh, Motonobu Oshimura, Mitsuo BMC Biotechnol Methodology Article BACKGROUND: Human artificial chromosome (HAC) vectors have some unique characteristics as compared with conventional vectors, carrying large transgenes without size limitation, showing persistent expression of transgenes, and existing independently from host genome in cells. With these features, HACs are expected to be promising vectors for modifications of a variety of cell types. However, the method of introduction of HACs into target cells is confined to microcell-mediated chromosome transfer (MMCT), which is less efficient than other methods of vector introduction. Application of Measles Virus (MV) fusogenic proteins to MMCT instead of polyethylene glycol (PEG) has partly solved this drawback, whereas the tropism of MV fusogenic proteins is restricted to human CD46- or SLAM-positive cells. RESULTS: Here, we show that retargeting of microcell fusion by adding anti-Transferrin receptor (TfR) single chain antibodies (scFvs) to the extracellular C-terminus of the MV-H protein improves the efficiency of MV-MMCT to human fibroblasts which originally barely express both native MV receptors, and are therefore resistant to MV-MMCT. Efficacy of chimeric fusogenic proteins was evaluated by the evidence that the HAC, tagged with a drug-resistant gene and an EGFP gene, was transferred from CHO donor cells into human fibroblasts. Furthermore, it was demonstrated that no perturbation of either the HAC status or the functions of transgenes was observed on account of retargeted MV-MMCT when another HAC carrying four reprogramming factors (iHAC) was transferred into human fibroblasts. CONCLUSIONS: Retargeted MV-MMCT using chimeric H protein with scFvs succeeded in extending the cell spectrum for gene transfer via HAC vectors. Therefore, this technology could facilitate the systematic cell engineering by HACs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12896-015-0142-z) contains supplementary material, which is available to authorized users. BioMed Central 2015-06-19 /pmc/articles/PMC4472177/ /pubmed/26088202 http://dx.doi.org/10.1186/s12896-015-0142-z Text en © Hiratsuka et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Methodology Article
Hiratsuka, Masaharu
Ueda, Kana
Uno, Narumi
Uno, Katsuhiro
Fukuhara, Sayaka
Kurosaki, Hajime
Takehara, Shoko
Osaki, Mitsuhiko
Kazuki, Yasuhiro
Kurosawa, Yoshikazu
Nakamura, Takafumi
Katoh, Motonobu
Oshimura, Mitsuo
Retargeting of microcell fusion towards recipient cell-oriented transfer of human artificial chromosome
title Retargeting of microcell fusion towards recipient cell-oriented transfer of human artificial chromosome
title_full Retargeting of microcell fusion towards recipient cell-oriented transfer of human artificial chromosome
title_fullStr Retargeting of microcell fusion towards recipient cell-oriented transfer of human artificial chromosome
title_full_unstemmed Retargeting of microcell fusion towards recipient cell-oriented transfer of human artificial chromosome
title_short Retargeting of microcell fusion towards recipient cell-oriented transfer of human artificial chromosome
title_sort retargeting of microcell fusion towards recipient cell-oriented transfer of human artificial chromosome
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472177/
https://www.ncbi.nlm.nih.gov/pubmed/26088202
http://dx.doi.org/10.1186/s12896-015-0142-z
work_keys_str_mv AT hiratsukamasaharu retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome
AT uedakana retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome
AT unonarumi retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome
AT unokatsuhiro retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome
AT fukuharasayaka retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome
AT kurosakihajime retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome
AT takeharashoko retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome
AT osakimitsuhiko retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome
AT kazukiyasuhiro retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome
AT kurosawayoshikazu retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome
AT nakamuratakafumi retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome
AT katohmotonobu retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome
AT oshimuramitsuo retargetingofmicrocellfusiontowardsrecipientcellorientedtransferofhumanartificialchromosome